Correlation Between Valneva SE and Day One
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Valneva SE and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Day One.
Diversification Opportunities for Valneva SE and Day One
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and Day is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Valneva SE i.e., Valneva SE and Day One go up and down completely randomly.
Pair Corralation between Valneva SE and Day One
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Day One. In addition to that, Valneva SE is 3.12 times more volatile than Day One Biopharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.11 per unit of volatility. If you would invest 1,334 in Day One Biopharmaceuticals on September 22, 2024 and sell it today you would lose (55.00) from holding Day One Biopharmaceuticals or give up 4.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Valneva SE ADR vs. Day One Biopharmaceuticals
Performance |
Timeline |
Valneva SE ADR |
Day One Biopharmaceu |
Valneva SE and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Valneva SE and Day One
The main advantage of trading using opposite Valneva SE and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |